Tatiana V. Ausheva
Tatiana V. Ausheva has a total of 97 co-authors. Here are the top co-authors by number of shared publications:
- Larisa N. Vashchenko
National Medical Research Centre for Oncology
6 shared publications - Irina Viktorovna Kaplieva
Rostov Research Institute of Oncology
5 shared publications - Elena Mikhaylovna Frantsiyants
National Medical Research Center of Oncology, Ministry of Health of Russia
4 shared publications - Oleg Ivanovich Kit
National Medical Research Centre for Oncology, Rostov-on-Don, Russia
4 shared publications - Svetlana Yu. Filippova
National Medical Research Center of Oncology, Ministry of Health of Russia
4 shared publications - Artem A. Barashev
National Medical Research Centre for Oncology
3 shared publications
Latest Publications
- Open Access
- 15 October 2026
- Published by Yakutsk Scientific Center for Complex Medical Problems in Yakut Medical Journal
- No. 3,p. 9-13
Comparative evaluation of the effectiveness of soft tissue sarcoma transplantation into tubular and flat bones during the formation of orthotopic PDX models
Soft tissue sarcomas (STS) are characterized by pronounced local aggressiveness, a high recurrence rate, and the potential for invasive growth into adjacent anatomical structures, including bone. In this study, we developed two methods for creating orthotopic models: transplanting tumor material into the femur (tubular) and pubic (flat) bones. In the first passage, 26 models were created (two for each of 13 donors). Transplantation into tubular bone demonstrated a higher engraftment rate-92.3% (12/13) versus 61.5% (8/13) for flat bone. In the second passage, 20 transplants were performed with an overall engraftment rate of 40.9% (9/20), resulting in six stably growing xenografts in tubular bones and three in flat bones. The more intense growth in the second passage reflects successful adaptation of the xenografts. The developed orthotopic PDX models of bone-invasive sarcomas represent a promising tool for preclinical research, enabling the study of the pathogenesis of tumor invasion, modeling the mechanisms of local sarcoma spread, and assessing the efficacy of anticancer drugs, including targeted and immunotherapeutic agents.
- 15 October 2026
- Published by Yakutsk Scientific Center for Complex Medical Problems in Yakut Medical Journal
- No. 3,p. 9-13
Open AccessComparative evaluation of the effectiveness of soft tissue sarcoma transplantation into tubular and flat bones during the formation of orthotopic PDX models
Soft tissue sarcomas (STS) are characterized by pronounced local aggressiveness, a high recurrence rate, and the potential for invasive growth into adjacent anatomical structures, including bone. In this study, we developed two methods for creating orthotopic models: transplanting tumor material into the femur (tubular) and pubic (flat) bones. In the first passage, 26 models were created (two for each of 13 donors). Transplantation into tubular bone demonstrated a higher engraftment rate-92.3% (12/13) versus 61.5% (8/13) for flat bone. In the second passage, 20 transplants were performed with an overall engraftment rate of 40.9% (9/20), resulting in six stably growing xenografts in tubular bones and three in flat bones. The more intense growth in the second passage reflects successful adaptation of the xenografts. The developed orthotopic PDX models of bone-invasive sarcomas represent a promising tool for preclinical research, enabling the study of the pathogenesis of tumor invasion, modeling the mechanisms of local sarcoma spread, and assessing the efficacy of anticancer drugs, including targeted and immunotherapeutic agents.
- 17 December 2025
- Published by ANO -Perspective of Oncology in South Russian Journal of Cancer
- Vol. 6 (4) , 26-35
Cytostatic effect of ricobendazole on primary cultures of soft tissue sarcomas in vitro
Soft tissue sarcomas (STS) are often resistant to treatment. The search for new antitumor compounds against STS remains an urgent task. Purpose of the study. To assess the sensitivity of primary STS cultures of various histological subtypes to albendazole sulfoxide (ricobendazole) and doxorubicin, the primary metabolite of albendazole. Materials and methods . STS tumor samples were used. The enzymatic dissociation method was used using 300 units/ml collagenase I (Thermo Fisher Scientific, USA). Ricasol® (NITA-PHARM, Russia) and Doxorubicin-LENS® (VEROPHARM, Russia) were used as test substances. Sensitivity to ricobendazole and doxorubicin was tested using the MTT test. The cultures were seeded in a 96‑well plate at 7,000 cells in DMEM medium with 10 % FSC added. After 24 h, the medium was replaced with PPS with ricobendazole in a series of two-fold dilutions from 35.5 μmol/l to 0.0347 μmol/l or doxorubicin from 10 μmol/l to 0.009 μmol/l. After 72 hours of incubation, the MTT test was performed. The cells were seeded in a 24‑well plate and cultured in PPS with 2 μmol/l ricabendazole for 72 h. Hoechst 33342 dye (Life Technologies, USA) was added to the culture at a concentration of 1 μg/ml, and photographs were taken using a LionHeart FX digital automatic microscope (BioTek Instruments Inc., USA). Results. Four primary sarcoma cultures were obtained: SAR‑1, SAR‑2, SAR‑3, and SAR‑4. SAR-1 and SAR-4. Cultures demonstrated the most rapid growth, with doubling times of 38 and 27 hours, respectively. The slowest proliferation was observed in the SAR-2 culture (doubling time 156 hours), while SAR-3 showed a doubling time of 45 hours. According to the MTT assay, the IC50 values for ricobendazole were 4.54 ± 1.2 μmol/L for SAR-1, 3.31 ± 0.7 μmol/L for SAR-3, and 1.51 ± 0.2 μmol/L for SAR-4, whereas the slowly dividing SAR-2 culture proved to be insensitive to ricobendazole. The cytostatic activity of doxorubicin was higher than that of ricobendazole. The SAR‑2 culture was the least sensitive (IC50 could not be determined), and SAR‑4 (IC50 SAR‑4 = 0.16 ± 0.01 μmol/l) was the most sensitive to the action of doxorubicin. The IC50 value of SAR‑1 = 0.64 ± 0.02 μmol/l and IC50 SAR‑3 = 1.8 ± 0.1 μmol/l. The effect of ricobendazole caused pronounced disturbances in the nuclei of SAR‑1 and SAR‑4 cultures, in SAR‑2 and SAR‑3 they were less pronounced. Conclusion. Ricobenzale had a cytostatic effect on primary STS cultures characterized by rapid cell growth, but the activity was lower than that of doxorubicin. Changes in the morphology of cells and nuclei indicated probable disturbances in the functioning of the spindle and cytoskeleton occurring under the action of this compound. Of particular interest for further research is the combination of ricobendazole with taxanes and other tubulin inhibitors.
- 17 December 2025
- Published by ANO -Perspective of Oncology in South Russian Journal of Cancer
- Vol. 6 (4) , 26-35
Cytostatic effect of ricobendazole on primary cultures of soft tissue sarcomas in vitro
Soft tissue sarcomas (STS) are often resistant to treatment. The search for new antitumor compounds against STS remains an urgent task. Purpose of the study. To assess the sensitivity of primary STS cultures of various histological subtypes to albendazole sulfoxide (ricobendazole) and doxorubicin, the primary metabolite of albendazole. Materials and methods . STS tumor samples were used. The enzymatic dissociation method was used using 300 units/ml collagenase I (Thermo Fisher Scientific, USA). Ricasol® (NITA-PHARM, Russia) and Doxorubicin-LENS® (VEROPHARM, Russia) were used as test substances. Sensitivity to ricobendazole and doxorubicin was tested using the MTT test. The cultures were seeded in a 96‑well plate at 7,000 cells in DMEM medium with 10 % FSC added. After 24 h, the medium was replaced with PPS with ricobendazole in a series of two-fold dilutions from 35.5 μmol/l to 0.0347 μmol/l or doxorubicin from 10 μmol/l to 0.009 μmol/l. After 72 hours of incubation, the MTT test was performed. The cells were seeded in a 24‑well plate and cultured in PPS with 2 μmol/l ricabendazole for 72 h. Hoechst 33342 dye (Life Technologies, USA) was added to the culture at a concentration of 1 μg/ml, and photographs were taken using a LionHeart FX digital automatic microscope (BioTek Instruments Inc., USA). Results. Four primary sarcoma cultures were obtained: SAR‑1, SAR‑2, SAR‑3, and SAR‑4. SAR-1 and SAR-4. Cultures demonstrated the most rapid growth, with doubling times of 38 and 27 hours, respectively. The slowest proliferation was observed in the SAR-2 culture (doubling time 156 hours), while SAR-3 showed a doubling time of 45 hours. According to the MTT assay, the IC50 values for ricobendazole were 4.54 ± 1.2 μmol/L for SAR-1, 3.31 ± 0.7 μmol/L for SAR-3, and 1.51 ± 0.2 μmol/L for SAR-4, whereas the slowly dividing SAR-2 culture proved to be insensitive to ricobendazole. The cytostatic activity of doxorubicin was higher than that of ricobendazole. The SAR‑2 culture was the least sensitive (IC50 could not be determined), and SAR‑4 (IC50 SAR‑4 = 0.16 ± 0.01 μmol/l) was the most sensitive to the action of doxorubicin. The IC50 value of SAR‑1 = 0.64 ± 0.02 μmol/l and IC50 SAR‑3 = 1.8 ± 0.1 μmol/l. The effect of ricobendazole caused pronounced disturbances in the nuclei of SAR‑1 and SAR‑4 cultures, in SAR‑2 and SAR‑3 they were less pronounced. Conclusion. Ricobenzale had a cytostatic effect on primary STS cultures characterized by rapid cell growth, but the activity was lower than that of doxorubicin. Changes in the morphology of cells and nuclei indicated probable disturbances in the functioning of the spindle and cytoskeleton occurring under the action of this compound. Of particular interest for further research is the combination of ricobendazole with taxanes and other tubulin inhibitors.
- Open Access
- 14 June 2024
- Published by Publishing House ABV Press in MD-Onco
- Vol. 4 (2) , 37-45
Results of venous resections and reconstructions in retroperitoneal tumors
Background. Retroperitoneal tumors are rare, heterogeneous malignant neoplasms. Due to the low sensitivity of tumor to chemoradiation, surgical resection is the only curative treatment method for retroperitoneal sarcomas. Performance of radical surgery improves the outcome for these patients. There are little data about the results of the treatment of the patients who underwent en bloc resection of the retroperitoneal tumors combined with the resection of large vessel.Aim. To analyze surgical and oncological outcomes of treatment retroperitoneal neoplasms with vascular involvement. Materials and methods. From 2019 to 2022, 27 patients with retroperitoneal sarcomas underwent surgical treatment with the resection of large vessels during the period.Results. The average diameter of the tumors was 17 (11–39) cm. The most common histological type was moderately differentiated liposarcoma (33.4 %), followed by pleomorphic liposarcoma (22.2 %), highly differentiated (18.5 %), undifferentiated sarcoma (18.5 %), leiomyosarcoma (7.4 %). Resection of the suprarenal segment of the inferior vena cava (IVC) with prosthetics was performed in 4 cases, resection of the renal segment with renal vein reimplantation – in 1 case, resection of the infrarenal segment of the IVC with prosthetics – in 8 cases. A synthetic prosthesis was used as a conduit in all cases. Tangential resection of the suprarenal IVC portion was performed in 1 patient, infrarenal portion – in 5 patients. A resection of the infrarenal IVC portion was performed without reconstruction in 1 case. Resection of the iliac vein was required in 6 patients; in one case the resection of the arterial iliac segment and prosthetics was added. Complete resection (R0–R1) was achieved in 85.2 % of the cases. The incidence of postoperative complications went as far as 25.9 % with no postoperative mortality. Despite ongoing anticoagulant therapy, the frequency of thrombosis in venous reconstruction zone in the early postoperative period (1 month) was 7.4 %. The median relapse-free survival was 16 months, and the median of overall survival was not achieved.Conclusion. Combined operations with the excision of retroperitoneal malignancies and angioplasty have explicitly acceptable level of postoperative complications and mortality. Eradication of retroperitoneal tumor with large vessels invasion allows to enlarge the life expectancy of patients often considered to be inoperable.
- 14 June 2024
- Published by Publishing House ABV Press in MD-Onco
- Vol. 4 (2) , 37-45
Open AccessResults of venous resections and reconstructions in retroperitoneal tumors
Background. Retroperitoneal tumors are rare, heterogeneous malignant neoplasms. Due to the low sensitivity of tumor to chemoradiation, surgical resection is the only curative treatment method for retroperitoneal sarcomas. Performance of radical surgery improves the outcome for these patients. There are little data about the results of the treatment of the patients who underwent en bloc resection of the retroperitoneal tumors combined with the resection of large vessel.Aim. To analyze surgical and oncological outcomes of treatment retroperitoneal neoplasms with vascular involvement. Materials and methods. From 2019 to 2022, 27 patients with retroperitoneal sarcomas underwent surgical treatment with the resection of large vessels during the period.Results. The average diameter of the tumors was 17 (11–39) cm. The most common histological type was moderately differentiated liposarcoma (33.4 %), followed by pleomorphic liposarcoma (22.2 %), highly differentiated (18.5 %), undifferentiated sarcoma (18.5 %), leiomyosarcoma (7.4 %). Resection of the suprarenal segment of the inferior vena cava (IVC) with prosthetics was performed in 4 cases, resection of the renal segment with renal vein reimplantation – in 1 case, resection of the infrarenal segment of the IVC with prosthetics – in 8 cases. A synthetic prosthesis was used as a conduit in all cases. Tangential resection of the suprarenal IVC portion was performed in 1 patient, infrarenal portion – in 5 patients. A resection of the infrarenal IVC portion was performed without reconstruction in 1 case. Resection of the iliac vein was required in 6 patients; in one case the resection of the arterial iliac segment and prosthetics was added. Complete resection (R0–R1) was achieved in 85.2 % of the cases. The incidence of postoperative complications went as far as 25.9 % with no postoperative mortality. Despite ongoing anticoagulant therapy, the frequency of thrombosis in venous reconstruction zone in the early postoperative period (1 month) was 7.4 %. The median relapse-free survival was 16 months, and the median of overall survival was not achieved.Conclusion. Combined operations with the excision of retroperitoneal malignancies and angioplasty have explicitly acceptable level of postoperative complications and mortality. Eradication of retroperitoneal tumor with large vessels invasion allows to enlarge the life expectancy of patients often considered to be inoperable.
- 23 January 2024
- Published by Media Sphere Publishing Group in Pirogov Russian Journal of Surgery
- No. 1,p. 119-126
Optimal prevention of VTE in cancer surgery patients with impaired renal function
Despite notable progress in the prevention of venous thromboembolic complications (VTE) and its widespread use in recent decades, mortality in cancer patients from VTE is still second only to the main disease. Some features and limitations in cancer patients, such as a decrease in kidney function and platelet count, an increased risk of bleeding, and the difficulty of monitoring the adequacy and safety of thromboprophylaxis, as well as the use of aggressive chemotherapy, determine the need for more effective and safer ways to solve the problem of VTE. Also, in the case of surgical interventions in such patients, the need for preoperative thromboprophylaxis raises new challenges for doctors. The article presents a review of the issue using a clinical case.
- 23 January 2024
- Published by Media Sphere Publishing Group in Pirogov Russian Journal of Surgery
- No. 1,p. 119-126
Optimal prevention of VTE in cancer surgery patients with impaired renal function
Despite notable progress in the prevention of venous thromboembolic complications (VTE) and its widespread use in recent decades, mortality in cancer patients from VTE is still second only to the main disease. Some features and limitations in cancer patients, such as a decrease in kidney function and platelet count, an increased risk of bleeding, and the difficulty of monitoring the adequacy and safety of thromboprophylaxis, as well as the use of aggressive chemotherapy, determine the need for more effective and safer ways to solve the problem of VTE. Also, in the case of surgical interventions in such patients, the need for preoperative thromboprophylaxis raises new challenges for doctors. The article presents a review of the issue using a clinical case.
- Open Access
- 19 November 2023
- Published by QUASAR, LLC in Research and Practical Medicine Journal
- Vol. 10 (4) , 8-21
Indicators of free radical oxidation in neutrophils of patients with primary and recurrent soft tissue sarcomas
Purpose of the study. To carry out a comparative analysis of lipid peroxidation intensity and antioxidant system indices in blood neutrophils of patients with primary and relapsed soft tissue sarcomas (STS) depending on sex and age.Patients and methods. Of the 81 patients included in the study, 48 had primary STS, 5 patients with continued growth, and 28 patients with recurrent STS. The patients were divided by sex and age; the level of lipid peroxidation products, superoxide dismutase (SOD) activity, total peroxidase activity (TPA), glutathione peroxidase (GPx) activity and reduced glutathione (RG) content in blood neutrophils were investigated by conventional spectrophotometric methods. The comparison groups (donors) consisted of 12 men and 17 women divided into the same age subgroups: ≤ 45 years and > 45 years.Results. In donors, there was a multiple decrease in the SOD/TPA ratio with age, especially in women, and in men this was accompanied by an age-related decrease in GPx activity. In primary sarcomas in older women and in men with continued growth and recurrence, there was an increase in diene conjugates (DC). In men over 45 years of age, there was an increase in SOD, TPA, and GPx. Women of the older age group were characterized by activation of SOD and GPx, expressed in the relapsed process to a significantly greater extent than in men, and an increase in RG was observed in women. The increase in both components of the glutathione system and SOD activity was especially significant in the development of relapses in women for periods exceeding three years, which was accompanied by a decrease in DC content. Conclusions. Neutrophils are characterized by an increase in DC content in patients of both sexes in the older age group with primary and recurrent STS, with its highest content in men with continued growth and relapses. GPx activity, increased in both men and women in the older age group in all variants of STS development, may play an important role in the antioxidant protection of blood cells in STS. Thus, the most pronounced activation of GPx, accompanied by a maximum increase in reduced glutathione and activation of SOD, contributes to a decrease in the level of DC and the absence of MDA increase in women with slow development of recurrences.
- 19 November 2023
- Published by QUASAR, LLC in Research and Practical Medicine Journal
- Vol. 10 (4) , 8-21
Open AccessIndicators of free radical oxidation in neutrophils of patients with primary and recurrent soft tissue sarcomas
Purpose of the study. To carry out a comparative analysis of lipid peroxidation intensity and antioxidant system indices in blood neutrophils of patients with primary and relapsed soft tissue sarcomas (STS) depending on sex and age.Patients and methods. Of the 81 patients included in the study, 48 had primary STS, 5 patients with continued growth, and 28 patients with recurrent STS. The patients were divided by sex and age; the level of lipid peroxidation products, superoxide dismutase (SOD) activity, total peroxidase activity (TPA), glutathione peroxidase (GPx) activity and reduced glutathione (RG) content in blood neutrophils were investigated by conventional spectrophotometric methods. The comparison groups (donors) consisted of 12 men and 17 women divided into the same age subgroups: ≤ 45 years and > 45 years.Results. In donors, there was a multiple decrease in the SOD/TPA ratio with age, especially in women, and in men this was accompanied by an age-related decrease in GPx activity. In primary sarcomas in older women and in men with continued growth and recurrence, there was an increase in diene conjugates (DC). In men over 45 years of age, there was an increase in SOD, TPA, and GPx. Women of the older age group were characterized by activation of SOD and GPx, expressed in the relapsed process to a significantly greater extent than in men, and an increase in RG was observed in women. The increase in both components of the glutathione system and SOD activity was especially significant in the development of relapses in women for periods exceeding three years, which was accompanied by a decrease in DC content. Conclusions. Neutrophils are characterized by an increase in DC content in patients of both sexes in the older age group with primary and recurrent STS, with its highest content in men with continued growth and relapses. GPx activity, increased in both men and women in the older age group in all variants of STS development, may play an important role in the antioxidant protection of blood cells in STS. Thus, the most pronounced activation of GPx, accompanied by a maximum increase in reduced glutathione and activation of SOD, contributes to a decrease in the level of DC and the absence of MDA increase in women with slow development of recurrences.
- Open Access
- 14 September 2023
- Published by Publishing House ABV Press in Bone and soft tissue sarcomas, tumors of the skin
- Vol. 15 (3) , 21-33
Redox status of blood lymphocytes in patients with soft tissue sarcomas
Introduction. The proven significance of free radical disorders in oncopathology determines the relevance of their study in soft tissue sarcomas (STS), which are characterized by a tendency to recurrence and high mortality of patients.Aim. To study the indicators of free radical oxidation and antioxidant protection in blood lymphocytes in primary and recurrent STS, depending on the sex and age of patients.Materials and methods. In 51 patients with primary STS, T2bN0M0 (17 men and 34 women) and in 34 patients (14 men and 20 women) with relapses, the level of lipid peroxidation products – malondialdehyde and diene conjugates, activities of superoxide dismutase and glutathione peroxidase, total peroxidase activity, the level of reduced glutathione were studied by spectrophotometric methods. Patients were divided by age: ≤45 years and 45 years. The comparison groups (donors) consisted of 12 men and 17 women divided into the same age subgroups.Results. In men 45 years old with primary sarcomas, there was an increase in diene conjugates by 2.2 times, with relapses by 2.4 times, and in young men - only with relapses by 2.6 times. The level of malondialdehyde in men did not change with primary sarcomas, with relapses it was reduced in both age groups by 2.4–2.6 times. In women with primary STS, there was an increase in most of the studied parameters in both age groups by 1.6–1.9 times. The increase in diene conjugates level and superoxide dismutase activity was the most pronounced (3 times) in patients of the older age group. The increase in glutathione peroxidase activity in primary STS in young women was 2.3 times, and in the older age group in patients of both sexes it was 5 times. In half of the women with relapses developed no earlier than 3 years after treatment, a decrease in both lipid peroxidation products by 2.6–3.4 times was found, and in all women almost 4-fold activation of superoxide dismutase and 8-fold glutathione peroxidase with an increase in the level of reduced glutathione by 7 times took place, which was significantly higher than in men. For women of the older age group, a 3-fold increase in the ratio of superoxide dismutase/total peroxidase activity is characteristic for primary STS and almost 5-fold for recurrence.Conclusion. In primary STS, the activation of lipid peroxidation products and antioxidant enzymes in women is more pronounced than in men. Changes in most indicators are more typical for patients of older age groups, in which relapse was accompanied by a decrease in malondialdehyde in patients of both sexes and maximum activation of superoxide dismutase and glutathione peroxidase in women.
- 14 September 2023
- Published by Publishing House ABV Press in Bone and soft tissue sarcomas, tumors of the skin
- Vol. 15 (3) , 21-33
Open AccessRedox status of blood lymphocytes in patients with soft tissue sarcomas
Introduction. The proven significance of free radical disorders in oncopathology determines the relevance of their study in soft tissue sarcomas (STS), which are characterized by a tendency to recurrence and high mortality of patients.Aim. To study the indicators of free radical oxidation and antioxidant protection in blood lymphocytes in primary and recurrent STS, depending on the sex and age of patients.Materials and methods. In 51 patients with primary STS, T2bN0M0 (17 men and 34 women) and in 34 patients (14 men and 20 women) with relapses, the level of lipid peroxidation products – malondialdehyde and diene conjugates, activities of superoxide dismutase and glutathione peroxidase, total peroxidase activity, the level of reduced glutathione were studied by spectrophotometric methods. Patients were divided by age: ≤45 years and 45 years. The comparison groups (donors) consisted of 12 men and 17 women divided into the same age subgroups.Results. In men 45 years old with primary sarcomas, there was an increase in diene conjugates by 2.2 times, with relapses by 2.4 times, and in young men - only with relapses by 2.6 times. The level of malondialdehyde in men did not change with primary sarcomas, with relapses it was reduced in both age groups by 2.4–2.6 times. In women with primary STS, there was an increase in most of the studied parameters in both age groups by 1.6–1.9 times. The increase in diene conjugates level and superoxide dismutase activity was the most pronounced (3 times) in patients of the older age group. The increase in glutathione peroxidase activity in primary STS in young women was 2.3 times, and in the older age group in patients of both sexes it was 5 times. In half of the women with relapses developed no earlier than 3 years after treatment, a decrease in both lipid peroxidation products by 2.6–3.4 times was found, and in all women almost 4-fold activation of superoxide dismutase and 8-fold glutathione peroxidase with an increase in the level of reduced glutathione by 7 times took place, which was significantly higher than in men. For women of the older age group, a 3-fold increase in the ratio of superoxide dismutase/total peroxidase activity is characteristic for primary STS and almost 5-fold for recurrence.Conclusion. In primary STS, the activation of lipid peroxidation products and antioxidant enzymes in women is more pronounced than in men. Changes in most indicators are more typical for patients of older age groups, in which relapse was accompanied by a decrease in malondialdehyde in patients of both sexes and maximum activation of superoxide dismutase and glutathione peroxidase in women.
- Open Access
- 7 March 2023
- Published by Autonomous non-profit scientific and medical organization - Questions of Oncology in Voprosy onkologii
- Vol. 69 (1) , 67-73
3D bioprinting of a breast tumor model
Introduction. 3D printing is a promising new method for building 3D cell constructs for all kinds of biomedical research. The advantages of using 3D bioprinting in the biomedical field include high precision, the opportunity to generate patient-specific tissue and to build complex structures. The main component of the 3D bioprinting is the bioink that ensures biocompatibility, mechanical stability, and high resolution during and after printing. Aim. To study the effect of curing method of gelatin methacryloyl (GelMA) and alginate bioink on the microstructure of the resulting 3D construct and on the morphological features of the encapsulated into bioink BT20 breast cancer cells. Materials and methods. In our study, we used the extrusion based 3D printing on a BIO X bioprinter (Cellink, USA) with gelatin methacryloyl (GelMA)-alginate bioinks mixed with BT-20 breast cancer cells in a ratio of 2:1. The printed constructs were polymerized in two ways, either chemically or by photo-curing. After curing, the constructs with cells were placed in DMEM medium supplemented with 10% FBS and cultured at 37°C and 5.5% CO2. The samples were then observed and visualized using a microscope (Ti-S, Nikon, Japan). After one and two weeks of cultivation, some of the constructs were fixed and encased in paraffin blocks. Then, according to the standard procedure, sections were prepared and stained with hematoxylin and eosin. Results. As a result, we constructed square, 3-layer constructs with encapsulated breast cancer cells. When creating 3D models of breast cancer growth using GelMA and alginate-based bioinks, in our opinion, photo-curing is preferable, as it allows to create a spongy microstructure of intercommunicating pores. Conclusion. This structure supports cell migration and helps to preserve similar to observed in vivo cell morphology. 3D печать - это новый многообещающий метод создания трехмерных клеточных конструкций для всевозможных биомедицинских исследований. К преимуществам использования 3D-биопечати в биомедицинской сфере относятся разработка персонализированного дизайна для каждого пациента, высокая точность и создание сложных структур. Основным компонентом 3D-биопечати являются биочернила, обеспечивающие биосовместимость, механическую стабильность, и высокое разрешение вовремя и после печати. Цель. Изучить влияние способа отверждения биочернил на основе метакрилата желатина и альгината на микроструктуру получаемого 3D конструкта и на морфологию инкапсулированных в него клеток рака молочной жедезы (РМЖ) ВТ20. В нашем исследовании мы использовали метод экструзионной 3D печати на биопринтере BIO X (Cellink, США) с биочернилами на основе альгината и метакрилата желатина GelMa, смешанные с клетками линии рака молочной железы BT-20 в соотношении 2:1. Напечатанные конструкты полимеризировали двумя способами химическим или фото- отверждением. После отверждения конструкты с клетками помещали в питательную среду DMEM с добавлением 10% FBS и культивировали при 37°С и 5,5% СО2. Затем образцы наблюдали и визуализировали с помощью микроскопа (Ti-S, Nikon, Япония). По истечении одной и двух недель культивирования часть конструктов фиксировали и заключали в парафиновые блоки. Далее по стандартной методике подготавливали срезы и окрашивали препараты гематоксилином и эозином. В результате мы спроектировали квадратные, 3-х слойные, конструкты с инкапсулированными клетками рака молочной железы. При создании 3D моделей опухолевого роста РМЖ с использованием биочернил на основе метакрилата желатина и альгината на наш взгляд, предпочтительным является фотоотверждение, так как оно позволяет создать губчатую микроструктуру из сообщающихся пор. Такая структура поддерживает миграцию клеток и способствует сохранению клеточной морфологии, приближенной к наблюдаемой in vivo.
- 7 March 2023
- Published by Autonomous non-profit scientific and medical organization - Questions of Oncology in Voprosy onkologii
- Vol. 69 (1) , 67-73
Open Access3D bioprinting of a breast tumor model
Introduction. 3D printing is a promising new method for building 3D cell constructs for all kinds of biomedical research. The advantages of using 3D bioprinting in the biomedical field include high precision, the opportunity to generate patient-specific tissue and to build complex structures. The main component of the 3D bioprinting is the bioink that ensures biocompatibility, mechanical stability, and high resolution during and after printing. Aim. To study the effect of curing method of gelatin methacryloyl (GelMA) and alginate bioink on the microstructure of the resulting 3D construct and on the morphological features of the encapsulated into bioink BT20 breast cancer cells. Materials and methods. In our study, we used the extrusion based 3D printing on a BIO X bioprinter (Cellink, USA) with gelatin methacryloyl (GelMA)-alginate bioinks mixed with BT-20 breast cancer cells in a ratio of 2:1. The printed constructs were polymerized in two ways, either chemically or by photo-curing. After curing, the constructs with cells were placed in DMEM medium supplemented with 10% FBS and cultured at 37°C and 5.5% CO2. The samples were then observed and visualized using a microscope (Ti-S, Nikon, Japan). After one and two weeks of cultivation, some of the constructs were fixed and encased in paraffin blocks. Then, according to the standard procedure, sections were prepared and stained with hematoxylin and eosin. Results. As a result, we constructed square, 3-layer constructs with encapsulated breast cancer cells. When creating 3D models of breast cancer growth using GelMA and alginate-based bioinks, in our opinion, photo-curing is preferable, as it allows to create a spongy microstructure of intercommunicating pores. Conclusion. This structure supports cell migration and helps to preserve similar to observed in vivo cell morphology. 3D печать - это новый многообещающий метод создания трехмерных клеточных конструкций для всевозможных биомедицинских исследований. К преимуществам использования 3D-биопечати в биомедицинской сфере относятся разработка персонализированного дизайна для каждого пациента, высокая точность и создание сложных структур. Основным компонентом 3D-биопечати являются биочернила, обеспечивающие биосовместимость, механическую стабильность, и высокое разрешение вовремя и после печати. Цель. Изучить влияние способа отверждения биочернил на основе метакрилата желатина и альгината на микроструктуру получаемого 3D конструкта и на морфологию инкапсулированных в него клеток рака молочной жедезы (РМЖ) ВТ20. В нашем исследовании мы использовали метод экструзионной 3D печати на биопринтере BIO X (Cellink, США) с биочернилами на основе альгината и метакрилата желатина GelMa, смешанные с клетками линии рака молочной железы BT-20 в соотношении 2:1. Напечатанные конструкты полимеризировали двумя способами химическим или фото- отверждением. После отверждения конструкты с клетками помещали в питательную среду DMEM с добавлением 10% FBS и культивировали при 37°С и 5,5% СО2. Затем образцы наблюдали и визуализировали с помощью микроскопа (Ti-S, Nikon, Япония). По истечении одной и двух недель культивирования часть конструктов фиксировали и заключали в парафиновые блоки. Далее по стандартной методике подготавливали срезы и окрашивали препараты гематоксилином и эозином. В результате мы спроектировали квадратные, 3-х слойные, конструкты с инкапсулированными клетками рака молочной железы. При создании 3D моделей опухолевого роста РМЖ с использованием биочернил на основе метакрилата желатина и альгината на наш взгляд, предпочтительным является фотоотверждение, так как оно позволяет создать губчатую микроструктуру из сообщающихся пор. Такая структура поддерживает миграцию клеток и способствует сохранению клеточной морфологии, приближенной к наблюдаемой in vivo.
- Open Access
- 21 December 2022
- Published by Publishing House ABV Press in Bone and soft tissue sarcomas, tumors of the skin
- Vol. 14 (4) , 45-53
Insulin-like growth factors and their transfer protein in the blood of patients with primary and recurrent soft tissue sarcomas
Introduction. Soft tissue sarcomas (STS) are rare diseases but their characteristic tendency for recurrence and high mortality dictate the need for the search for prognostic biomarkers for identification of patients with the risk of recurrence. In this context, the system of insulin-like growth factors (IGF) and their insulin-like growth factor-binding proteins (IGFBP) is of interest because it was shown that disruption of the IGF system regulation leads to cancer cell proliferation and migration and chemotherapy resistance.The study objective is to investigate the levels of the IGF system components in blood of patients with primary and recurrent STS.Materials and methods. In total, 54 patients with STS, T2bN0M0, were examined: 12 men and 12 women with primary STS, 10 men and 20 women with recurrent STS, as well as healthy donors (10 men and 10 women). Mean patient age was 63.1 ± 0.9 years. In blood sampled prior to treatment, the levels of insulin-like growth factor 1 (IGF1), insulin-like growth factor 2 (IGF2) and insulin-like growth factor-binding protein 2 (IGFBP2) were measured by ELISA using Mediagnost kits (Germany). Statistical analysis was performed using Statistica 10 software and non-parametric Mann-Whitney test.Results. In primary STS, the levels of IGF1 in men with G3–4 tumors and all women decreased 14- and 20-fold, respectively, compared to healthy donors. Additionally, an insignificant decrease of IGF2 level in men and a decrease of IGF1/IGF2 ratio by the factor of 8.8 in men with G3–4 tumors and by the factor of 24.3 in women were observed. In recurrences, IGF1 level decreased by 40 % in men and by 78–85.5 % in women, while IGF2 level in men with G3–4 tumors decreased by 19 %, in women increased by 21–58 % compared to donors. In women with primary STS and recurrences of G3–4 tumors, IGFBP2 was also elevated. In men with G3–4 tumors, changes in IGFBP2 levels were less significant and had an opposite trend compared to women.Conclusion. STS recurrence is accompanied by imbalance of IGF system components in blood, especially in patients of both sexes with G3–4 tumors. Correlation between increased IGFBP2 level in STS and clinical characteristics of the disease, especially in recurrence, suggest prognostic significance of this molecule.
- 21 December 2022
- Published by Publishing House ABV Press in Bone and soft tissue sarcomas, tumors of the skin
- Vol. 14 (4) , 45-53
Open AccessInsulin-like growth factors and their transfer protein in the blood of patients with primary and recurrent soft tissue sarcomas
Introduction. Soft tissue sarcomas (STS) are rare diseases but their characteristic tendency for recurrence and high mortality dictate the need for the search for prognostic biomarkers for identification of patients with the risk of recurrence. In this context, the system of insulin-like growth factors (IGF) and their insulin-like growth factor-binding proteins (IGFBP) is of interest because it was shown that disruption of the IGF system regulation leads to cancer cell proliferation and migration and chemotherapy resistance.The study objective is to investigate the levels of the IGF system components in blood of patients with primary and recurrent STS.Materials and methods. In total, 54 patients with STS, T2bN0M0, were examined: 12 men and 12 women with primary STS, 10 men and 20 women with recurrent STS, as well as healthy donors (10 men and 10 women). Mean patient age was 63.1 ± 0.9 years. In blood sampled prior to treatment, the levels of insulin-like growth factor 1 (IGF1), insulin-like growth factor 2 (IGF2) and insulin-like growth factor-binding protein 2 (IGFBP2) were measured by ELISA using Mediagnost kits (Germany). Statistical analysis was performed using Statistica 10 software and non-parametric Mann-Whitney test.Results. In primary STS, the levels of IGF1 in men with G3–4 tumors and all women decreased 14- and 20-fold, respectively, compared to healthy donors. Additionally, an insignificant decrease of IGF2 level in men and a decrease of IGF1/IGF2 ratio by the factor of 8.8 in men with G3–4 tumors and by the factor of 24.3 in women were observed. In recurrences, IGF1 level decreased by 40 % in men and by 78–85.5 % in women, while IGF2 level in men with G3–4 tumors decreased by 19 %, in women increased by 21–58 % compared to donors. In women with primary STS and recurrences of G3–4 tumors, IGFBP2 was also elevated. In men with G3–4 tumors, changes in IGFBP2 levels were less significant and had an opposite trend compared to women.Conclusion. STS recurrence is accompanied by imbalance of IGF system components in blood, especially in patients of both sexes with G3–4 tumors. Correlation between increased IGFBP2 level in STS and clinical characteristics of the disease, especially in recurrence, suggest prognostic significance of this molecule.
- 8 September 2022
- Published by Publishing House OKI in Antibiot Khimioter = Antibiotics and Chemotherapy
- Vol. 67 (5-6) , 30-38
Etiological Characteristics in Causative Agents of Infectious Complications in Cancer Patients
Этиологическая характеристика возбудителей инфекционных осложнений у онкологических больных
- 8 September 2022
- Published by Publishing House OKI in Antibiot Khimioter = Antibiotics and Chemotherapy
- Vol. 67 (5-6) , 30-38
Etiological Characteristics in Causative Agents of Infectious Complications in Cancer Patients
Этиологическая характеристика возбудителей инфекционных осложнений у онкологических больных
- Open Access
- 31 August 2022
- Published by ANO -Perspective of Oncology in South Russian Journal of Cancer
- Vol. 3 (3) , 6-14
FEATURES OF REPLACEMENT OF EXTENSIVE POST-RESECTION BONE DEFECTS IN PELVIC AND SACRAL TUMORS
Опыт двухэтапного хирургического лечения больных с обширными пострезекционными костными дефектами при опухолях таза и крестца
- 31 August 2022
- Published by ANO -Perspective of Oncology in South Russian Journal of Cancer
- Vol. 3 (3) , 6-14
Open AccessFEATURES OF REPLACEMENT OF EXTENSIVE POST-RESECTION BONE DEFECTS IN PELVIC AND SACRAL TUMORS
Опыт двухэтапного хирургического лечения больных с обширными пострезекционными костными дефектами при опухолях таза и крестца